| Evaluation of wound healing activity of Piper betle leaves and stem extract in experimental Wistar rats KC Nilugal, K Perumal, RE Ugander, AI Chittor Am. J. PharmTech Res 4 (3), 276-289, 2014 | 35 | 2014 |
| Prognostic biomarkers in renal cell carcinoma: is there a relationship with obesity? R Rajandram, K Perumal, NY Yap Translational andrology and urology 8 (Suppl 2), S138, 2019 | 18 | 2019 |
| Cancer nanomedicine and immune system—Interactions and challenges S Ahmad, RAM Idris, WN Wan Hanaffi, K Perumal, JC Boer, M Plebanski, ... Frontiers in Nanotechnology 3, 681305, 2021 | 17 | 2021 |
| A study on the immunohistochemical expressions of leptin and leptin receptor in clear cell renal cell carcinoma K Perumal, KS Mun, NY Yap, AHA Razack, GC Gobe, TA Ong, ... BioMed Research International 2020 (1), 3682086, 2020 | 11 | 2020 |
| Nanoparticles and gut microbiota in colorectal cancer K Perumal, S Ahmad, MH Mohd-Zahid, WN Wan Hanaffi, I ZA, JL Six, ... Frontiers in Nanotechnology 3, 681760, 2021 | 9 | 2021 |
| Circulating adiponectin as a biomarker in renal cell carcinoma: a systematic review and meta-analysis NY Yap, FN Yap, K Perumal, R Rajandram Biomarkers 24 (6), 607-614, 2019 | 8 | 2019 |
| Potential value of visfatin, omentin-1, nesfatin-1 and apelin in Renal Cell Carcinoma (RCC): a systematic review and meta-analysis SM Chinapayan, S Kuppusamy, NY Yap, K Perumal, G Gobe, ... Diagnostics 12 (12), 3069, 2022 | 7 | 2022 |
| Role of leptin as a biomarker for early detection of renal cell carcinoma? No evidence from a systematic review and meta-analysis K Perumal, WK Huin, NY Yap, TA Ong, GC Gobe, R Rajandram Medical Hypotheses 129, 109239, 2019 | 4 | 2019 |
| Practical updates in medical therapy for advanced and metastatic renal cell carcinoma NY Yap, WT Khoo, K Perumal, KA Ng, R Rajandram, A Alip, M Saad, ... Urological Science 29 (3), 120-128, 2018 | 2 | 2018 |
| Plasma homocysteine level and carotid intima–media thickness in type 2 diabetic patients KK Perumal, K Santha, S Sethupathy, S Sethurajan, KB Mahendran, ... International Journal of Medical Science and Public Health 4 (10), 1404-1409, 2015 | 1 | 2015 |
| Prevalence and treatment of human epidermal growth factor receptor 2-altered non-small cell lung cancer: a retrospective analysis and systematic literature review NY Yap, K Perumal, P Rajadurai ecancermedicalscience 18, 1734, 2024 | | 2024 |
| 587P Exploring the prevalence and characteristics of human epidermal growth factor receptor 2 (HER2) alterations in non-small cell lung cancer: Analysis from a Malaysian cohort NY Yap, K Perumal, P Rajadurai Annals of Oncology 34, S1699-S1700, 2023 | | 2023 |
| A review of visfatin, omentin-1, nesfatin-1 and apelin as a potential biomarker in renal cell carcinoma (RCC) SM Chinapayan, S Kuppusamy, NY Yap, K Perumal, G Gobe, ... BJU INTERNATIONAL 130, 11-12, 2022 | | 2022 |
| An exploration of leptin and leptin receptor protein expressions in clear cell renal cell carcinoma tissue and their association with obesity K Perumal, K Mun, N Yap, AA Razack, S Kuppusamy, G Gobe, T Ong, ... Bju International 123, 79-80, 2019 | | 2019 |
| Adiponectin as a prediction marker in renal cell carcinoma-a meta-analysis study N Yap, F Yap, K Perumal, R Rajandram BJU INTERNATIONAL 123, 80-80, 2019 | | 2019 |
| Association between obesity and renal cell carcinoma: A single centre retrospective study YX Foong, NY Yap, K Perumal, R Rajandram, TA Ong BJU INTERNATIONAL 122, 30-30, 2018 | | 2018 |
| A meta-analysis of adiponectin as a prediction marker in renal cell carcinoma NY Yap, FN Yap, K Perumal, R Rajandram BJU INTERNATIONAL 122, 12-12, 2018 | | 2018 |
| The evaluation of Leptin as an appropriate biomarker for the early detection of renal cell carcinoma (RCC): A systematic review and meta-analysis K Perumal, WK Huin, NY Yap, TA Ong, GC Gobe, R Rajandram BJU International 122, 13-13, 2018 | | 2018 |
Yap Ning YiLaboratory, Subang Jaya Medical Centre在 rsdhealth.com 的电子邮件经过验证
